The Safety and Efficacy of Microporous Polysaccharide Hemospheres in Terms of the Complication Rates in Total Hip Arthroplasty for Femoral Neck Fractures: A Control-Matched Retrospective Cohort
Abstract
:1. Background
2. Materials and Methods
3. Results
3.1. Demographic Data
3.2. Case–Control Matched Comparisons
3.3. Complications and Adverse Events
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Oslock, W.M.; Satiani, B.; Way, D.P.; Tamer, R.M.; Maurer, J.; Hawley, J.D.; Sharp, K.L.; Williams, T.E.; Pawlik, T.M.; Ellison, E.C.; et al. A contemporary reassessment of the US surgical workforce through 2050 predicts continued shortages and increased productivity demands. Am. J. Surg. 2022, 223, 28–35. [Google Scholar] [CrossRef] [PubMed]
- Borgström, F.; Karlsson, L.; Ortsäter, G.; Norton, N.; Halbout, P.; Cooper, C.; Lorentzon, M.; McCloskey, E.V.; Harvey, N.C.; Javaid, M.K.; et al. Fragility fractures in Europe: Burden, management and opportunities. Arch. Osteoporos. 2020, 15, 59. [Google Scholar] [CrossRef] [PubMed]
- Li, L.; Bennett-Brown, K.; Morgan, C.; Dattani, R. Hip fractures. Br. J. Hosp. Med. 2020, 81, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Tseng, F.-J.; Chia, W.-T.; Pan, R.-Y.; Lin, L.-C.; Shen, H.-C.; Wang, C.-H.; Shyu, J.-F.; Weng, C.-F. Comparison of arthroplasty vs. osteosynthesis for displaced femoral neck fractures: A meta-analysis. J. Orthop. Surg. Res. 2017, 12, 131. [Google Scholar] [CrossRef] [PubMed]
- Lewis, D.P.; Wæver, D.; Thorninger, R. Hemiarthroplasty vs Total Hip Arthroplasty for the Management of Displaced Neck of Femur Fractures: A Systematic Review and Meta-Analysis. J. Arthroplast. 2019, 34, 1837–1843. [Google Scholar] [CrossRef] [PubMed]
- Swart, E.; Roulette, P.; Leas, D.; Bozic, K.J.; Karunakar, M. ORIF or arthroplasty for displaced femoral neck fractures in patients younger than 65 years old: An economic decision analysis. J. Bone Jt. Surg. Am. 2017, 99, 65–75. [Google Scholar] [CrossRef] [PubMed]
- Ruggiero, C.; Pioli, G.; Petruccelli, R.; Baroni, M.; Prampolini, R.; Pignedoli, P.; Antinolfi, P.; Rinonapoli, G.; Cappa, M.; Boccardi, V.; et al. The correlates of post-surgical haematoma in older adults with proximal femoral fractures. Aging Clin. Exp. Res. 2023, 35, 867–875. [Google Scholar] [CrossRef] [PubMed]
- Mortazavi, S.M.; Hansen, P.; Zmistowski, B.; Kane, P.W.; Restrepo, C.; Parvizi, J. Hematoma following primary total hip arthroplasty: A grave complication. J. Arthroplast. 2013, 28, 498–503. [Google Scholar] [CrossRef]
- Saleh, K.; Olson, M.; Resig, S.; Bershadsky, B.; Kuskowski, M.; Gioe, T.; Robinson, H.; Schmidt, R.; McElfresh, E. Predictors of wound infection in hip and knee joint replacement: Results from a 20 year surveillance program. J. Orthop. Res. 2002, 20, 506–515. [Google Scholar] [CrossRef]
- Boddapati, V.; Fu, M.C.; Tetreault, M.W.; Blevins, J.L.; Richardson, S.S.; Su, E.P. Short-term Complications After Revision Hip Arthroplasty for Prosthetic Joint Infection Are Increased Relative to Noninfectious Revisions. J. Arthroplast. 2018, 33, 2997–3002. [Google Scholar] [CrossRef]
- Venishetty, N.; Beale, J.; Martinez, J.; Mounasamy, V.; Sambandam, S. Understanding factors that impact the length of stay after total hip arthroplasty—A national in-patient sample-based study. J. Clin. Orthop. Trauma 2023, 46, 102284. [Google Scholar] [CrossRef]
- Pathak, N.; Bovonratwet, P.; Purtill, J.; Bernstein, J.A.; Golden, M.; Grauer, J.N.; Rubin, L.E. Incidence, Risk Factors, and Subsequent Complications of Postoperative Hematomas Requiring Reoperation After Primary Total Hip Arthroplasty. Arthroplast. Today 2023, 19, 101015. [Google Scholar] [CrossRef]
- Girbino, K.L.; Klika, A.K.; Barsoum, W.K.; Bloomfield, M.R.; Briskin, I.N.; Brooks, P.J.; Higuera, C.A.; Kamath, A.F.; Krebs, V.E.; McLaughlin, J.P.; et al. Understanding the main predictors of length of stay after total hip arthroplasty: Patient-related or procedure-related risk factors? J. Arthroplast. 2021, 36, 1663–1670.e4. [Google Scholar] [CrossRef]
- Collinge, C.A.; Kelly, K.C.; Little, B.; Weaver, T.; Schuster, R.D. The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery. J. Orthop. Trauma 2012, 26, 568–573. [Google Scholar] [CrossRef]
- Griffiths, R.; Babu, S.; Dixon, P.; Freeman, N.; Hurford, D.; Kelleher, E.; Moppett, I.; Ray, D.; Sahota, O.; Shields, M.; et al. Guideline for the management of hip fractures 2020: Guideline by the Association of Anaesthetists. Anaesthesia 2021, 76, 225–237. [Google Scholar] [CrossRef]
- Papachristos, I.V.; Giannoudis, P.V. Proximal femur fractures in patients taking anticoagulants. EFORT Open Rev. 2020, 5, 699–706. [Google Scholar] [CrossRef]
- Schuetze, K.; Eickhoff, A.; Dehner, C.; Gebhard, F.; Richter, P.H. Impact of oral anticoagulation on proximal femur fractures treated within 24 h: A retrospective chart review. Injury 2019, 50, 2040–2044. [Google Scholar] [CrossRef]
- Kolodychuk, N.L.; Godshaw, B.; Nammour, M.; Starring, H.; Mautner, J. Early hip fracture surgery is safe for patients on direct oral anticoagulants. OTA Int. 2023, 6, e252. [Google Scholar] [CrossRef]
- Giannoudi, M.; Giannoudis, P.V. Proximal femur fractures in patients taking anticoagulants: Has anything changed? EFORT Open Rev. 2022, 7, 356–364. [Google Scholar] [CrossRef]
- de Jong, L.; Klem, T.M.A.L.; Kuijper, T.M.; Roukema, G.R. Factors affecting the rate of surgical site infection in patients after hemiarthroplasty of the hip following a fracture of the neck of the femur. Bone Jt. J. 2017, 99-B, 1088–1094. [Google Scholar] [CrossRef]
- Liu, X.; Dong, Z.; Li, J.; Feng, Y.; Cao, G.; Song, X.; Yang, J. Factors affecting the incidence of surgical site infection after geriatric hip fracture surgery: A retrospective multicenter study. J. Orthop. Surg. Res. 2019, 14, 382. [Google Scholar] [CrossRef]
- Wall, P.V.; Mitchell, B.C.; Ta, C.N.; Kent, W.T. Review of perioperative outcomes and management of hip fracture patients on direct oral anticoagulants. EFORT Open Rev. 2023, 8, 561–571. [Google Scholar] [CrossRef]
- Bourget-Murray, J.; Horton, I.; Morris, J.; Bureau, A.; Garceau, S.; Abdelbary, H.; Grammatopoulos, G. Periprosthetic joint infection following hip hemiarthroplasty. Bone Jt. Open 2022, 3, 924–932. [Google Scholar] [CrossRef]
- Fillingham, Y.A.; Ramkumar, D.B.; Jevsevar, D.S.; Yates, A.J.; Shores, P.; Mullen, K.; Bini, S.A.; Clarke, H.D.; Schemitsch, E.; Johnson, R.L.; et al. The Efficacy of Tranexamic Acid in Total Hip Arthroplasty: A Network Meta-Analysis. J. Arthroplast. 2018, 33, 3083–3089.E4. [Google Scholar] [CrossRef]
- Bai, J.; Zhang, P.; Liang, Y.; Wang, J.; Wang, Y. Efficacy and safety of tranexamic acid usage in patients undergoing posterior lumbar fusion: A meta-analysis. BMC Musculoskelet. Disord. 2019, 20, 390. [Google Scholar] [CrossRef]
- Zhang, Y.; Liu, H.; He, F.; Chen, A.; Yang, H.; Pi, B. Does tranexamic acid improve bleeding, transfusion, and hemoglobin level in patients undergoing multilevel spine surgery? A systematic review and meta-analysis. World Neurosurg. 2019, 127, 289–301. [Google Scholar] [CrossRef]
- Haase, D.; Templeton, K.; Rosenthal, H.; Sweeney, K. Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction. J. Am. Acad. Orthop. Surg. 2020, 28, 248–255. [Google Scholar] [CrossRef]
- Tsantes, A.G.; Trikoupis, I.G.; Papadopoulos, D.V.; Goumenos, S.; Piovani, D.; Nikolopoulos, G.K.; Gialeraki, A.; Bonovas, S.; Papagelopoulos, P.J.; Kontogeorgakos, V.A.; et al. The Safety and Efficacy of Tranexamic Acid in Oncology Patients Undergoing Endoprosthetic Reconstruction and a ROTEM-Based Evaluation of Their Hemostatic Profile: A Pilot Study. Cancers 2021, 13, 3951. [Google Scholar] [CrossRef]
- Bruckner, B.A.; Blau, L.N.; Rodriguez, L.; Suarez, E.E.; Ngo, U.Q.; Reardon, M.J.; Loebe, M. Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures. J. Cardiothorac. Surg. 2014, 9, 134. [Google Scholar] [CrossRef]
- Lewis, K.; Atlee, H.; Mannone, A.; Lin, L.; Goppelt, A. Efficacy of hemostatic matrix and microporous polysaccharide hemospheres. J. Surg. Res. 2015, 193, 825–830. [Google Scholar] [CrossRef]
- Spotnitz, W.D.; Burks, S. Hemostats, sealants, and adhesives: Components of the surgical toolbox. Transfusion 2008, 48, 1502–1516. [Google Scholar] [CrossRef]
- Offodile, A.C., II; Chen, B.; Aherrera, A.S.; Guo, L. Microporous polysaccharide hemospheres potentiate ischemia-induced skin flap necrosis in a murine model. J. Plast. Reconstr. Surg. 2017, 139, 59e–66e. [Google Scholar] [CrossRef]
- Liu, T.-S.; Wang, Q.; Wang, H.; Liu, A.-P.; Ma, J.-C. Microporous polysaccharide hemospheres reduce blood loss in total hip arthroplasty. Chin. J. Tissue Eng. Res. 2015, 19, 1872–1877. [Google Scholar]
- Luo, D.-F.; Chen, Y.-P.; Gao, H.; Chen, L.; Li, S.-Z. Application of microporous polysaccharide hemospheres in total hip arthroplasty. Chin. J. Tissue Eng. Res. 2012, 16, 26. [Google Scholar]
- Gleason, S.; Mehl, D.; Payne, W.; Parry, S.; Stein, A.B. Microporous polysaccharide hemosphere efficacy and safety in primary total knee arthroplasty. J. Orthop. 2018, 16, 19–24. [Google Scholar] [CrossRef]
- McNally, M.; Sousa, R.; Wouthuyzen-Bakker, M.; Chen, A.F.; Soriano, A.; Vogely, H.C.; Clauss, M.; Higuera, C.A.; Trebše, R. The EBJIS definition of periprosthetic joint infection. Bone Jt. J. 2021, 103-B, 18–25. [Google Scholar] [CrossRef]
- Galat, D.D.; McGovern, S.C.; Hanssen, A.D.; Larson, D.R.; Harrington, J.R.; Clarke, H.D. Early return to surgery for evacuation of a postoperative hematoma after primary total knee arthroplasty. J. Bone Jt. Surg. Am. 2008, 90, 2331–2336. [Google Scholar] [CrossRef]
- Sizer, S.C.; Cherian, J.J.; Elmallah, R.D.K.; Pierce, T.P.; Beaver, W.B.; Mont, M.A. Predicting blood loss in total knee and hip arthroplasty. Orthop. Clin. N. Am. 2015, 46, 445–459. [Google Scholar] [CrossRef]
- Tanghe, K.K.; Chalmers, B.P.; Blevins, J.L.; Figgie, M.P.; Carli, A.V.; Agrusa, C.J.; Sculco, P.K.; Gausden, E.B. Hemostatic Agents in Orthopedic Surgery. HSS J. 2023, 19, 247–253. [Google Scholar] [CrossRef]
- Gabay, M.; Boucher, B.A. An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis. J. Pharmacother. 2013, 33, 935–955. [Google Scholar] [CrossRef]
- Menovsky, T.; Plazier, M.; Rasschaert, R.; Maas, A.I.R.; Parizel, P.M.; Verbeke, S. Massive swelling of Surgicel® FibrillarTM hemostat after spinal surgery. Case report and a review of the literature. Minim. Invasive Neurosurg. 2011, 54, 257–259. [Google Scholar]
- Hong, G.J.; Wilson, L.A.; Liu, J.; Memtsoudis, S.G. Tranexamic Acid Administration is Associated with a Decreased Odds of Prosthetic Joint Infection Following Primary Total Hip and Primary Total Knee Arthroplasty: A National Database Analysis. J. Arthroplast. 2021, 36, 1109–1113. [Google Scholar] [CrossRef]
- Liu, X.; Liu, J.; Sun, G. A comparison of combined intravenous and topical administration of tranexamic acid with intravenous tranexamic acid alone for blood loss reduction after total hip arthroplasty: A meta-analysis. Int. J. Surg. 2017, 41, 34–43. [Google Scholar] [CrossRef]
- Zhang, P.; Liang, Y.; Chen, P.; Fang, Y.; He, J.; Wang, J. Intravenous versus topical tranexamic acid in primary total hip replacement: A meta-analysis. Medicine 2016, 95, e5573. [Google Scholar] [CrossRef]
- Chen, S.; Wu, K.; Kong, G.; Feng, W.; Deng, Z.; Wang, H. The efficacy of topical tranexamic acid in total hip arthroplasty: A meta-analysis. BMC Musculoskelet. Disord. 2016, 17, 81. [Google Scholar] [CrossRef]
- Kim, C.; Park, S.S.-H.; Davey, J.R. Tranexamic acid for the prevention and management of orthopedic surgical hemorrhage: Current evidence. J. Blood Med. 2015, 6, 239–244. [Google Scholar] [CrossRef]
- Murat, F.J.; Ereth, M.H.; Dong, Y.; Piedra, M.P.; Gettman, M.T. Evaluation of microporous polysaccharide hemospheres as a novel hemostatic agent in open partial nephrectomy: Favorable experimental results in the porcine model. J. Urol. 2004, 172, 1119. [Google Scholar] [CrossRef] [PubMed]
- Wiseman, C. Arista® AH Randomized Clinical Study; Davol Inc.: Warwick, RI, USA, 2014; pp. 1–7. [Google Scholar]
- Miller, K.J.; Cao, W.; Ibrahim, M.M.; Levinson, H. The effect of microporous polysaccharide hemospheres on wound healing and scarring in wild-type and Db/Db mice. J. Adv. Skin Wound Care 2017, 30, 170–180. [Google Scholar] [CrossRef]
- Ereth, M.H.; Schaff, M.; Ericson, E.F.; Wetjen, N.M.; Nuttall, G.A.; Oliver, W.C. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model. Neurosurgery 2008, 63, 369. [Google Scholar] [CrossRef] [PubMed]
- Emmez, H.; Tonge, M.; Tokgoz, N.; Durdag, E.; Gonul, I.; Cevıker, N. Radiological and histopathological comparison of microporous polysaccharide hemospheres and oxidized regenerated cellulose in the rabbit brain: A study of efficacy and safety. Turk. Neurosurg. 2010, 20, 485. [Google Scholar] [CrossRef] [PubMed]
- Antisdel, J.L.; Matijasec, J.L.; Ting, J.Y.; Sindwani, R. Microporous polysaccharide hemospheres do not increase synechiae after sinus surgery: Randomized controlled study. Am. J. Rhinol. Allergy 2011, 25, 268–271. [Google Scholar] [CrossRef] [PubMed]
- Tschan, C.A.; Nie, M.; Schwandt, E.; Oertel, J. Safety and efficacy of microporous polysaccharide hemospheres in neurosurgery. Neurosurgery 2011, 69, 49–63. [Google Scholar] [CrossRef] [PubMed]
- Humphreys, M.R.; Castle, E.P.; Andrews, P.E.; Gettman, M.T.; Ereth, M.H. Microporous polysaccharide hemospheres for management of laparoscopic trocar injury to the spleen. Am. J. Surg. 2008, 195, 99. [Google Scholar] [CrossRef] [PubMed]
- Badarudeen, S.; Shu, A.C.; Ong, K.L.; Baykal, D.; Lau, E.; Malkani, A.L. Complications after revision total hip arthroplasty in the medicare population. J. Arthroplast. 2017, 32, 1954–1958. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pidgaiska, O.; Niemann, M.; Braun, K.; Trampuz, A.; Goumenos, S.; Stöckle, U.; Meller, S. The Safety and Efficacy of Microporous Polysaccharide Hemospheres in Terms of the Complication Rates in Total Hip Arthroplasty for Femoral Neck Fractures: A Control-Matched Retrospective Cohort. Life 2024, 14, 177. https://doi.org/10.3390/life14020177
Pidgaiska O, Niemann M, Braun K, Trampuz A, Goumenos S, Stöckle U, Meller S. The Safety and Efficacy of Microporous Polysaccharide Hemospheres in Terms of the Complication Rates in Total Hip Arthroplasty for Femoral Neck Fractures: A Control-Matched Retrospective Cohort. Life. 2024; 14(2):177. https://doi.org/10.3390/life14020177
Chicago/Turabian StylePidgaiska, Olga, Marcel Niemann, Karl Braun, Andrej Trampuz, Stavros Goumenos, Ulrich Stöckle, and Sebastian Meller. 2024. "The Safety and Efficacy of Microporous Polysaccharide Hemospheres in Terms of the Complication Rates in Total Hip Arthroplasty for Femoral Neck Fractures: A Control-Matched Retrospective Cohort" Life 14, no. 2: 177. https://doi.org/10.3390/life14020177